MTOR and glioblastoma: We found that, in iNs induced by the reprogramming treatment of ROCK-mTOR inhibitors, expressions of a set of neurogenic transcription factors were increased by > 10-fold (Fig. 3c), suggesting that these factors may be involved in GBM-neuron conversion.